Replies to post #412877 on Anavex Life Sciences Corp (AVXL)

[peeved]

quite flabbergasting that people

are not enraged that the markets are flying, even XBI and we are near 2 year lows. Everyone is back to the commercialization bandwagon....without any endpoint data

as a shareholder I am irate...of course I am not allowed to express my anger because I don't tow the WGT line....

frustrating that a drug that can potentially do so much is failed by a management that can be so inept.

[tschussmann1]

Frrol: I took your challenge.
"Look at another stock's daily chart, at 4pm. What do you see? See other days too. Now what does it "feel like"? Be wary of confirmation bias."

I first considered 3 stocks trading on the OTC, each with daily volume in the millions, so not too thinly traded. Each had minimal volume at the close as a percentage of the total: less than 5%. The stocks were DPLS, AITX, and OZSC if you are interested. Next I looked at 3 NYSE to Nasdaq stocks: AAPL, GLW, and TSLA. The end of day trading was about 15% of total volume for the first two, and 3% for TSLA. AVXL was close to 30%. My interpretation is that the OTC stocks have mostly retail traders, so little end of market trading. The NYS/Nasdaq stocks would clearly have institutional interest, so MOC trading might be appropriate. TSLA volume was so huge (122 million shares) that MOC as a precent of total was still small. AVXL was close to 30% of total on 4/28, and has been rather high a couple days prior as well. I would be surprised if this is due to retail. What I have found does not refute my hypothesis of either stealth accumulation or short covering...as the purpose of the MOC purchase as I see it is to minimize share price movement.